Hypertension is a major cause of cardiovascular diseases, with damage to target organs constituting the principal source of morbidity and mortality. In addition to the health burden, these problems also translate into huge costs for the Medicare budget. There is evidence that damage to target organs does not correlate well with the severity of hypertension, but might rather be explained by susceptibility factors, including genetic ones. Our long-term objectives are to identify genes linked to two important complications of hypertension: (1) left ventricular hypertrophy (L.H.), and (2) hypertension-induced renal damage (HIRD). Since such complex disease manifestations are typically controlled by several genes that have weak effects, it is difficult to detect such genes directly in humans. One alternative is to use animal models of such conditions and, after finding candidate genes, to extrapolate these findings to humans. We will therefore use genetically pure line of rodents that constitute models for L.H. and HIRD, and cross them to the other inbred strains to generate genetic segregating populations. The progeny of these crosses will be extensively phenotyped and genotyped in order identify quantitative trait loci (QTL) linked to either L.H. or HIRD. Subsequently, congenic lines will be generated to: (1) validate the effects of the QTLs, and (2) provide models to perform experiments aimed at identifying candidate mechanisms and candidate genes linked to the trait of interest.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL069122-02
Application #
6527884
Study Section
Special Emphasis Panel (ZHL1-CSR-E (S1))
Program Officer
Barouch, Winifred
Project Start
2001-09-30
Project End
2005-08-31
Budget Start
2002-09-01
Budget End
2003-08-31
Support Year
2
Fiscal Year
2002
Total Cost
$249,030
Indirect Cost
Name
Clinical Research Institute of Montreal
Department
Type
DUNS #
City
Montreal
State
QC
Country
Canada
Zip Code
H2 1-R7
Deschepper, Christian F (2010) Cardioprotective actions of cyclic GMP: lessons from genetic animal models. Hypertension 55:453-8
Llamas, Bastien; Belanger, Sonia; Picard, Sylvie et al. (2007) Cardiac mass and cardiomyocyte size are governed by different genetic loci on either autosomes or chromosome Y in recombinant inbred mice. Physiol Genomics 31:176-82
Deschepper, Christian F; Llamas, Bastien (2007) Hypertensive cardiac remodeling in males and females: from the bench to the bedside. Hypertension 49:401-7
Llamas, Bastien; Lau, Catherine; Cupples, William A et al. (2006) Genetic determinants of systolic and pulse pressure in an intercross between normotensive inbred rats. Hypertension 48:921-6
Souzeau, Emmanuelle; Llamas, Bastien; Belanger, Sonia et al. (2006) A genetic locus accentuates the effect of volume overload on adverse left ventricular remodeling in male and female rats. Hypertension 47:128-33
Llamas, Bastien; Jiang, Zhibin; Rainville, Marie-Line et al. (2005) Distinct QTLs are linked to cardiac left ventricular mass in a sex-specific manner in a normotensive inbred rat inter-cross. Mamm Genome 16:700-11
Souzeau, Emmanuelle; Belanger, Sonia; Picard, Sylvie et al. (2005) Dietary isoflavones during pregnancy and lactation provide cardioprotection to offspring rats in adulthood. Am J Physiol Heart Circ Physiol 289:H715-21
Llamas, Bastien; Deschepper, Christian F (2005) Identification and validation of Loci and candidate genes linked to cardiac hypertrophy. Methods Mol Med 112:321-37
Zahabi, Ahmad; Picard, Sylvie; Fortin, Nadia et al. (2003) Expression of constitutively active guanylate cyclase in cardiomyocytes inhibits the hypertrophic effects of isoproterenol and aortic constriction on mouse hearts. J Biol Chem 278:47694-9